Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered in New York City. The company develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
FDA expanded approval of Pfizer/Seagen's Padcev plus Merck's Keytruda combination to muscle-invasive bladder cancer (MIBC), intensifying competitive pressure on AstraZeneca's checkpoint inhibitor.
Despite an overall survival miss, Leerink Partners said Pfizer’s antibody-drug conjugate showed “promising” signals of efficacy in a subgroup of patients who had undergone only one prior line of treatment.